Our Story: Rewriting the Script to Outmatch Disease
Nurix, built on pioneering research in E3 ligases, has transformed into a leader in targeted protein degradation. By leveraging expertise in translating degradation science into clinical breakthroughs, Nurix aims to redefine treatment paradigms.
Leadership: Championing Breakthroughs for Patients
Backed by a team of E3 ubiquitin ligase regulation experts and seasoned biotech executives, Nurix is driving the development of revolutionary medicines based on targeted protein degradation. The leadership at Nurix is dedicated to accelerating the pace of innovation for patient care.
Partnering: Strategic Collaborations for Impactful Discoveries
Strategic partnerships with industry giants like Gilead Sciences, Sanofi, and Pfizer have amplified Nurix's influence in drug discovery and development. These collaborations expand the horizon of possibilities for targeted protein degradation therapies, promising a brighter future for healthcare.
Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive
seamless operations, and scale effortlessly for long-term success.
Book a Meeting to Avail the Services of Nurix